2025-04-05 - Analysis Report
## TEM: Unknown Company Stock Review

**0. Key Figures:**

* **Cumulative Return (TEM):** 14.67%
* **Cumulative Return (VOO):** -20.62%
* **Current Price:** $42.58
* **5-Day Moving Average:** $47.87
* **20-Day Moving Average:** $48.99
* **60-Day Moving Average:** $54.48
* **Market Risk Indicator (MRI):** 0.4693 (High Risk)


**1. Performance Comparison:**

Unknown Company (TEM) significantly outperformed the S&P 500 (VOO) over the analyzed period.  The cumulative return difference is a substantial 35.29 percentage points (14.67% - (-20.62%)).  The relative outperformance is situated at the 39.9th percentile of its historical range, indicating a relatively strong performance compared to its historical volatility against the S&P 500. The provided CAGR of 15% for 2023-2025 further supports this positive performance, despite a high maximum drawdown (MDD) of 76.4%.  The high beta (7.3) suggests high volatility and sensitivity to market movements.  An alpha of 0.0 indicates that the stock's performance is largely explained by market movements.  The market cap is listed as 7.3 Billion.

**2. Recent Price Movement:**

The recent price of $42.58 represents a significant drop (-7.78%) from the previous close of $46.17.  The price is below all three moving averages (5-day, 20-day, and 60-day), suggesting a bearish short-term trend.

**3. Technical Indicators & Expected Return:**

* **RSI (48.72):**  Near the neutral level (50), suggesting neither overbought nor oversold conditions.
* **PPO (-0.0962):** Negative, indicating bearish momentum.
* **Delta_Previous_Relative_Divergence (-5.9):** Shows a recent decline in relative performance against the S&P 500.
* **Expected Return (nan):**  The expected return is not provided, hindering a comprehensive analysis of long-term potential compared to the S&P 500.  The high risk indicated by the MRI should be taken into consideration when projecting long-term returns. The substantial recent price drop (-7.78%) warrants further investigation into potential underlying causes.

**4. Recent Earnings Analysis:**

| Date       | EPS    | Expected EPS |
|------------|--------|-------------|
| 2025-02-24 | -0.18  | -0.15       |
| 2024-11-04 | -0.25  | -0.26608     |
| 2024-08-06 | -0.63  | -0.59       |

TEM has consistently reported negative earnings per share (EPS) over the past three quarters. While the company slightly beat expectations in the November and February quarters, the August quarter showed significant underperformance. This negative trend raises concerns regarding the company's profitability.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue      | Profit Margin |
|---------|-------------|---------------|
| 2024-12-31 | $0.20B      | 60.83%        |
| 2024-09-30 | $0.18B      | 58.50%        |
| 2024-06-30 | $0.17B      | 45.50%        |
| 2024-03-31 | $0.15B      | 53.28%        |
| 2023-12-31 | $0.15B      | 55.20%        |


**Capital and Profitability:**

| Quarter | Equity       | ROE           |
|---------|-------------|---------------|
| 2024-12-31 | $0.06B      | -23.10%       |
| 2024-09-30 | $0.05B      | -141.16%      |
| 2024-06-30 | $0.10B      | -562.04%      |
| 2024-03-31 | $-1.47B     | 4.39%         |
| 2023-12-31 | $-1.38B     | 3.65%         |

Revenue shows a consistent growth trend, while profit margins are generally high but fluctuated throughout the year. However, the Capital and Profitability section reveals serious concerns.  Extremely negative Return on Equity (ROE) figures in Q2 and Q3 2024 point to significant financial distress.  Negative equity further underlines this concerning financial situation.  The substantial improvement in ROE in Q4 2024 might be a positive sign, but further analysis is needed to understand the cause and sustainability.


**6. Overall Analysis:**

TEM shows a strong relative performance compared to the S&P 500, particularly in the longer term, as evidenced by its cumulative return and CAGR.  However, this performance should be viewed cautiously.  Recent price action and negative earnings raise serious short-term concerns. The high beta highlights significant market sensitivity, and the high risk indicator (MRI) indicates a volatile investment.  More importantly, the alarmingly negative ROE and negative equity in several quarters signal severe financial problems for the Unknown Company.  While the recent improvement is promising,  a deep dive into the underlying reasons for this improvement and future projections are needed before making any investment decisions.  The significant negative EPS and the uncertainty around the future profitability overshadow the positive relative return against the S&P 500.  Further investigation is necessary to assess the long-term viability and investment suitability of TEM.  Given the available data, the high risk associated with this stock outweighs the potential rewards.
